PHILADELPHIA — Jeremy Levin is a doctor, a gun owner, an immigrant, and the former CEO of the largest generic drug manufacturer in the world. Now, he’s also the board chair of BIO, the biotech trade organization.
Born in South Africa and educated abroad, Levin speaks at least four languages — French, Hebrew, Afrikaans, and English — and he used two of them in his first speech to the organization’s membership on Wednesday morning at the BIO International Convention.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
